Health & Biotech
Radiopharmaceutical emerges as the hottest space in biotech; here’s what it means for Clarity Pharma
Health & Biotech
ASX Health Stocks: Patrys and Next Science jump after presenting data on studies
Health & Biotech
MoneyTalks: Brokers name ASX health stocks Percheron and Probiotec as ones to watch
Health & Biotech
Melodiol welcomes Chuck’s petition to pass US SAFER Banking Act
Health & Biotech
AdAlta and SYNthesis BioVentures collaborate on advanced cell-based cancer immunotherapy
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Blinklab soars 32.5% in first healthcare IPO of 2024
Health & Biotech
Online sales of Calmer Co wellness products surpasses 10k per day for March
Health & Biotech
‘Overnight success story 18 years in the making’ – Imricor to transform cardiac ablation market
Health & Biotech
ASX Health Winners March: A rebound? Aussie biotech sector is on the radar of Asian investors
Health & Biotech
ASX Health Stocks: Acrux jumps 70pc after launching its acne gel in the US
Health & Biotech
Anteris Technologies is leading a heart condition treatment revolution
Health & Biotech
Medtech Optiscan beefs up operations in US, hires two high-level execs
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.